v3.26.1
Document And Entity Information
Mar. 24, 2026
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 24, 2026
Entity Registrant Name Maze Therapeutics, Inc.
Entity Central Index Key 0001842295
Entity Emerging Growth Company true
Entity File Number 001-42490
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 82-2635018
Entity Address, Address Line One 171 Oyster Point Blvd., Suite 300
Entity Address, City or Town South San Francisco
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94080
City Area Code 650
Local Phone Number 850-5070
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Ex Transition Period false
Title of 12(b) Security Common Stock - par value $0.001 per share
Trading Symbol MAZE
Security Exchange Name NASDAQ